Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives
Onchocerciasis and lymphatic filariasis (LF) are human filarial diseases belonging to the group of neglected tropical diseases, leading to permanent and long-term disability in infected individuals in the endemic countries such as Africa and India. Microfilaricidal drugs such as ivermectin and alben...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medknow Publications and Media
2019
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/80694/1/WOLBACHIA.pdf |
| _version_ | 1796980801227718656 |
|---|---|
| author | Wan Sulaiman, Wan Aliaa Kamtchum-Tatuene, Joseph Mohamed, Mohd Hazmi Ramachandran, Vasudevan Siew, Mooi Ching Mohd Sazlly Lim, Sazlyna Hashim, Hasnur Zaman Inche Mat, Liyana Najwa Fan, Kee Hoo Basri, Hamidon |
| author_facet | Wan Sulaiman, Wan Aliaa Kamtchum-Tatuene, Joseph Mohamed, Mohd Hazmi Ramachandran, Vasudevan Siew, Mooi Ching Mohd Sazlly Lim, Sazlyna Hashim, Hasnur Zaman Inche Mat, Liyana Najwa Fan, Kee Hoo Basri, Hamidon |
| author_sort | Wan Sulaiman, Wan Aliaa |
| collection | UPM |
| description | Onchocerciasis and lymphatic filariasis (LF) are human filarial diseases belonging to the group of neglected tropical diseases, leading to permanent and long-term disability in infected individuals in the endemic countries such as Africa and India. Microfilaricidal drugs such as ivermectin and albendazole have been used as the standard therapy in filariasis, although their efficacy in eliminating the diseases is not fully established. Anti-Wolbachia therapy employs antibiotics and is a promising approach showing potent macrofilaricidal activity and also prevents embryogenesis. This has translated to clinical benefits resulting in successful eradication of microfilarial burden, thus averting the risk of adverse events from target species as well as those due to co-infection with loiasis. Doxycycline shows potential as an anti-Wolbachia treatment, leading to the death of adult parasitic worms. It is readily available, cheap and safe to use in adult non-pregnant patients. Besides doxycycline, several other potential antibiotics are also being investigated for the treatment of LF and onchocerciasis. This review aims to discuss and summarise recent developments in the use of anti-Wolbachia drugs to treat onchocerciasis and LF. |
| first_indexed | 2024-03-06T10:28:23Z |
| format | Article |
| id | upm.eprints-80694 |
| institution | Universiti Putra Malaysia |
| language | English |
| last_indexed | 2024-03-06T10:28:23Z |
| publishDate | 2019 |
| publisher | Medknow Publications and Media |
| record_format | dspace |
| spelling | upm.eprints-806942020-11-04T13:13:25Z http://psasir.upm.edu.my/id/eprint/80694/ Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives Wan Sulaiman, Wan Aliaa Kamtchum-Tatuene, Joseph Mohamed, Mohd Hazmi Ramachandran, Vasudevan Siew, Mooi Ching Mohd Sazlly Lim, Sazlyna Hashim, Hasnur Zaman Inche Mat, Liyana Najwa Fan, Kee Hoo Basri, Hamidon Onchocerciasis and lymphatic filariasis (LF) are human filarial diseases belonging to the group of neglected tropical diseases, leading to permanent and long-term disability in infected individuals in the endemic countries such as Africa and India. Microfilaricidal drugs such as ivermectin and albendazole have been used as the standard therapy in filariasis, although their efficacy in eliminating the diseases is not fully established. Anti-Wolbachia therapy employs antibiotics and is a promising approach showing potent macrofilaricidal activity and also prevents embryogenesis. This has translated to clinical benefits resulting in successful eradication of microfilarial burden, thus averting the risk of adverse events from target species as well as those due to co-infection with loiasis. Doxycycline shows potential as an anti-Wolbachia treatment, leading to the death of adult parasitic worms. It is readily available, cheap and safe to use in adult non-pregnant patients. Besides doxycycline, several other potential antibiotics are also being investigated for the treatment of LF and onchocerciasis. This review aims to discuss and summarise recent developments in the use of anti-Wolbachia drugs to treat onchocerciasis and LF. Medknow Publications and Media 2019 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/80694/1/WOLBACHIA.pdf Wan Sulaiman, Wan Aliaa and Kamtchum-Tatuene, Joseph and Mohamed, Mohd Hazmi and Ramachandran, Vasudevan and Siew, Mooi Ching and Mohd Sazlly Lim, Sazlyna and Hashim, Hasnur Zaman and Inche Mat, Liyana Najwa and Fan, Kee Hoo and Basri, Hamidon (2019) Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives. Indian Journal of Medical Research, 149 (6). pp. 706-714. ISSN 0971-5916 https://www.ijmr.org.in/article.asp?issn=0971-5916;year=2019;volume=149;issue=6;spage=706;epage=714;aulast=Wan 10.4103/ijmr.IJMR_454_17 |
| spellingShingle | Wan Sulaiman, Wan Aliaa Kamtchum-Tatuene, Joseph Mohamed, Mohd Hazmi Ramachandran, Vasudevan Siew, Mooi Ching Mohd Sazlly Lim, Sazlyna Hashim, Hasnur Zaman Inche Mat, Liyana Najwa Fan, Kee Hoo Basri, Hamidon Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives |
| title | Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives |
| title_full | Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives |
| title_fullStr | Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives |
| title_full_unstemmed | Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives |
| title_short | Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives |
| title_sort | anti wolbachia therapy for onchocerciasis lymphatic filariasis current perspectives |
| url | http://psasir.upm.edu.my/id/eprint/80694/1/WOLBACHIA.pdf |
| work_keys_str_mv | AT wansulaimanwanaliaa antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT kamtchumtatuenejoseph antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT mohamedmohdhazmi antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT ramachandranvasudevan antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT siewmooiching antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT mohdsazllylimsazlyna antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT hashimhasnurzaman antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT inchematliyananajwa antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT fankeehoo antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives AT basrihamidon antiwolbachiatherapyforonchocerciasislymphaticfilariasiscurrentperspectives |